Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000295603 | SCV000332728 | uncertain significance | not provided | 2015-07-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080742 | SCV001001868 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021088 | SCV005024371 | likely benign | Inborn genetic diseases | 2023-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001080742 | SCV001463169 | likely benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2020-06-07 | no assertion criteria provided | clinical testing |